Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

Upside Trend Intact For ASX200

Dec 02 2014 - Technicals

Michael Gable of Fairmont Equities suggests the sudden fall in the ASX200 means reassessment, but further weakness would provide opportunity in the upside trend.

Uranium Week: Most Volatile Month Since Fukushima

Dec 02 2014 - Commodities

The surge and pullback experienced in the spot uranium price in November reflected the highest level of volatility since the Japanese tsunami and reactor accident.

The Fallout From OPEC

Dec 01 2014 - Commodities

Whereto for the oil price now, and which Australian enrgy companies will be hurt the most by lower oil prices?

Regulatory Blow For Challenger But Stock Remains Attractive

Dec 01 2014 - Australia

The Commonwealth Department of Social Security has reversed a favourable tax treatment for Challenger Financial’s aged care annuities Brokers review the implications.

Weekly Recommendation, Target Price, Earnings Forecast Changes

Dec 01 2014 - Australia

Weekly update on recommendation, target price, and earnings forecast changes.

ASX200 Targeting 5000

Dec 01 2014 - Technicals

Nick Linton-Ffrost of Fifth Wave suggests the ASX200 to move towards 5000 over the next 3-4 weeks.

Mayne Pharma: Short Term Set Backs, But Potential Remains

Dec 01 2014 - Small Caps

While Mayne Pharma’s weak sales are disappointing, brokers point to the long-term potential of the stock.

General Disappointment Weighs Down Investor Enthusiasm

Nov 28 2014 - FYI

The results of the November Australian Investors’ Sentiment Survey are out, and they make for a sobering assessment.

Your Editor On Twitter

Nov 28 2014 - FYI

This week’s Tweets on Twitter by Your Editor.

Mesoblast’s GvHD Therapy Could Be Pivotal

Nov 27 2014 - Australia

Baillieu Holst is enthusiastic about Mesoblast’s plans to launch stem cell therapy for GvHD in 2016 and believes upside potential for the stock is substantial.

« Older Stories
Newer Stories »

Analyse The Market From A Different Angle

ICARUS SIGNAL

Consensus price targets can be a useful tool to assess whether stocks are running too hard, or falling too deeply.
R-FACTOR

Relative ranking of ASX200 stocks in accordance with consensus forecasts for growth, valuation and yield.
SENTIMENT INDICATOR

Evaluate circa 400 ASX-listed stocks on the basis of High/Low expert sentiment, forecast dividend yield.

Latest News

1
The Market In Numbers – 8 Aug 2026

9:09 AM - Australia
2
ASX Winners And Losers Of Today – 07-08-26

Aug 07 2026 - Daily Market Reports
3
FNArena Corporate Results Monitor – 07-08-2026

Aug 07 2026 - Australia
4
Next Week At A Glance – 10-14 Aug 2026

Aug 07 2026 - Weekly Reports
5
Pinnacle’s FY26 ‘Messy’ But Positive

Aug 07 2026 - Australia

Most Popular

1
Uranium Week: India Boosts U308 Demand

Jul 14 2026 - Weekly Reports
2
FNArena Corporate Results Monitor – 31-07-2026

Jul 31 2026 - Australia
3
Material Matters: Copper, Aluminium And Zircon

Jul 13 2026 - Commodities
4
The Overnight Report: A Positive End To July

Jul 31 2026 - Daily Market Reports
5
Rudi’s View: July’s Stock Pickers’ Favourites

Jul 09 2026 - Rudi's View
6
The Short Report – 23 Jul 2026

Jul 23 2026 - Weekly Reports